Home > Insider Trading > Filing (0001209191-14-076006)

Filing Details

Accession Number:: 0001209191-14-076006
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-16 19:02:14
Reporting Period:: 2014-12-12

Filing Date:: 2014-12-16
Accepted Time:: 2014-12-16 19:02:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1069899	Phibro Animal Health Corp	PAHC	Pharmaceutical Preparations (2834)	131840497

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363803	L.p. Mayflower	22 Grenville Street St. Helier Y9 JE4 8PX		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2014-12-12	26,547	$0.00	1,955,914	No	4	S	Indirect	SeeFootnote
Class A Common Stock	Disposition	2014-12-15	22,167	$0.00	1,933,747	No	4	S	Indirect	SeeFootnote
Class A Common Stock	Disposition	2014-12-16	54,244	$0.00	1,879,503	No	4	S	Indirect	SeeFootnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	SeeFootnote
No	4	S	Indirect	SeeFootnote
No	4	S	Indirect	SeeFootnote

Footnotes

Shares were sold in multiple transactions at a weighted average price of $31.3186 per share at prices ranging from $30.94 to $31.73. The reporting persons undertake to provide Phibro Animal Health Corp (the "Issuer"),any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares were sold in multiple transactions at a weighted average price of $29.9403 per share at prices ranging from $29.1312 to $31.13. The reporting persons undertake to provide the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares were sold in multiple transactions at a weighted average price of $29.397 per share at prices ranging from $29.00 to $29.77. The reporting persons undertake to provide the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares are directly held by Mayflower LP ("Mayflower"). Investment and divestment decisions with respect to the shares held by Mayflower are made by the investment committee of 3i Investments plc, which is the manager of Mayflower. 3i Investments plc is an indirect wholly owned subsidiary of 3i Group plc, a public company listed on the London Stock Exchange. 3i Investments plc is advised by 3i Corporation, which is also an indirect wholly owned subsidiary of 3i Group plc.